Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03948139 · ClinicalTrials.gov registry record · NA
Femur Fracture: Functional Bracing vs. Hip Spica Cast
A NA study of Pediatric Femur Fracture, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
- 2
- Study locations
NCT03948139: Completed NA study of Pediatric Femur Fracture, sponsored by Children's Hospital Los Angeles.
NCT03948139 is a NA study of Pediatric Femur Fracture that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 92 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03948139, a NA study of Pediatric Femur Fracture, has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
- 2
- Study locations
Study Summary
Spica casting is the current standard of care when treating pediatric diaphyseal femur fractures in the 0-5 year age group. A study conducted by Kramer et al. suggests there are both clinical and financial benefits of functional bracing when compared to spica casting. To this date there have been no prospective trials to evaluate these two treatment options. The investigators plan to conduct a multi-center randomized-control trial that will compare the subjective, objective and financial aspects of functional bracing and spica casting for pediatric femur fractures.
Primary Outcome
After treatment, leg length will be measured using clinical radiographs to determine if there are any changes to leg length and determine if there are discrepancies.
Conditions Studied
Interventions
- DEVICE Functional Brace
- DEVICE Hip Spica Cast
Study Locations (2)
California
- Children's Hospital Los Angeles - Los Angeles
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2018-10-16 |
| Est. Completion | 2025-02-11 |
| Phase | NA |
What the finished NCT03948139 record still lists
NCT03948139 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Pediatric Femur Fracture appearing as the primary indexed condition, and to 2 interventions - of which Functional Brace is the first listed.
NCT03948139 reports a single indexed study location in California, Colorado.
Frequently Asked Questions
What is clinical trial NCT03948139 about?
NCT03948139 is a clinical study titled "Femur Fracture: Functional Bracing vs. Hip Spica Cast". Spica casting is the current standard of care when treating pediatric diaphyseal femur fractures in the 0-5 year age group. A study conducted by Kramer et al. suggests there are both clinical and financial benefits of functional bracing when compared to spica casting. To this date there have been no...
What is the current status of trial NCT03948139?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2018-10-16. Estimated completion is 2025-02-11.
What conditions does trial NCT03948139 study?
This clinical trial studies the following conditions: Pediatric Femur Fracture.
What interventions are being tested in trial NCT03948139?
The interventions under investigation include: Functional Brace (DEVICE), Hip Spica Cast (DEVICE).
Who is sponsoring clinical trial NCT03948139?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03948139 being conducted?
This trial has 2 study locations across California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03948139's enrollment target sits among peer trials
92 937th of 2000 higher than 1,062 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI